1-5 of 5
Lei Zhang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract LB-A17: Discovery and characterization of a novel small molecule antagonist of PD-L1

Free
Haiyan Ying, Fei Yang, Mingming Zhang, Yongxian Zhang, Yuan Zhao, Xin Chen, Lei Zhang, Hongping Yu, Zhui Chen, Yao-chang Xu
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2019) 18 (12_Supplement): LB-A17.
https://doi.org/10.1158/1535-7163.TARG-19-LB-A17
Published: 01 December 2019
View articletitled, Abstract LB-A17: Discovery and characterization of a novel small molecule antagonist of PD-L1
Journal Articles

Discovery of A Novel EGFR-Targeting Antibody–Drug Conjugate, SHR-A1307, for the Treatment of Solid Tumors Resistant or Refractory to Anti-EGFR Therapies

Free
Kaijie He, Jianyan Xu, Jindong Liang, Jiahua Jiang, Mi Tang, Xin Ye, Zhebin Zhang, Lei Zhang, Beibei Fu, Yan Li, Chang Bai, Lianshan Zhang, Weikang Tao
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2019) 18 (6): 1104–1114.
https://doi.org/10.1158/1535-7163.MCT-18-0854
Published: 03 June 2019
View articletitled, Discovery of A Novel EGFR-Targeting Antibody–Drug Conjugate, SHR-A1307, for the Treatment of Solid Tumors Resistant or Refractory to Anti-EGFR Therapies
Open the PDF for Discovery of A Novel EGFR-Targeting Antibody–Drug Conjugate, SHR-A1307, for the Treatment of Solid Tumors Resistant or Refractory to Anti-EGFR Therapies in another window
Includes: Supplementary data
Journal Articles

Abstract B171: Traditional Chinese medicine (TCM) herbal mixture LQ targets lung cancer metastasis.

Free
Lei Zhang, Chengyu Wu, Yong Zhang, Fang Liu, Xiaoen Wang, Ming Zhao, Robert M. Hoffman
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2013) 12 (11_Supplement): B171.
https://doi.org/10.1158/1535-7163.TARG-13-B171
Published: 01 November 2013
View articletitled, Abstract B171: Traditional Chinese medicine (TCM) herbal mixture LQ targets lung cancer metastasis.
Journal Articles

Abstract C254: Discovery of a novel and potent BRAF (V600E) inhibitor with a unique kinase targeting profile, EBI-907: Pharmacological characterization and potential to overcome drug resistance and paradoxical activation.

Free
Jiayin Zhang, Dong Liu, Ru Shen, Yinfa Yan, Liuqing Yang, Minsheng Zhang, Guoqing Cao, Hu Cao, Beibei Fu, Aishen Gong, Biao Lu, Qiming Sun, Hong Wan, Pangke Yan, Lei Zhang, Lianshan Zhang, Jingsong Cao
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2013) 12 (11_Supplement): C254.
https://doi.org/10.1158/1535-7163.TARG-13-C254
Published: 01 November 2013
View articletitled, Abstract C254: Discovery of a novel and potent BRAF (V600E) inhibitor with a unique kinase targeting profile, EBI-907: Pharmacological characterization and potential to overcome drug resistance and paradoxical activation.
Journal Articles

2-[(1-Methylpropyl)dithio]-1H-imidazole inhibits tubulin polymerization through cysteine oxidation

Free
Kelly Huber, Poulam Patel, Lei Zhang, Helen Evans, Andrew D. Westwell, Peter M. Fischer, Stephen Chan, Stewart Martin
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2008) 7 (1): 143–151.
https://doi.org/10.1158/1535-7163.MCT-07-0486
Published: 17 January 2008
View articletitled, 2-[(1-Methylpropyl)dithio]-1H-imidazole inhibits tubulin polymerization through cysteine oxidation
Open the PDF for 2-[(1-Methylpropyl)dithio]-1H-imidazole inhibits tubulin polymerization through cysteine oxidation in another window